ProShare Advisors LLC

Position in MGTX — MeiraGTx Holdings plc

CIK 1357955 BETHESDA, MD

Position in MGTX

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$147,340

+$59,390 QoQ

Shares Held

10,906

+7.4% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#115

of 156 holders

Holding Since

Dec 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ProShare Advisors LLC holds $336,334,656 across 174 Biotechnology names. MGTX ranks #120 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	287,847	$142,982,240
2	REGN	Regeneron Pharmaceuticals, Inc.	119,240	$74,350,909
3	ALNY	Alnylam Pharmaceuticals, Inc.	128,514	$38,686,569
4	INCY	Incyte Corp	48,152	$5,458,510
5	MRNA	Moderna, Inc.	70,621	$4,945,588
6	CYTK	Cytokinetics Inc	27,121	$2,310,437
7	TECH	BIO-TECHNE Corp	30,597	$2,161,678
8	KRYS	Krystal Biotech, Inc.	4,760	$1,769,149

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$147,340	10,906	+7.4%	Shares	Sole	2026-08-11
2026-03-31	$87,950	10,156	-13.8%	Shares	Sole	2026-04-27
2025-12-31	$93,651	11,780	+2.0%	Shares	Sole	2026-02-06
2025-06-30	$75,279	11,546	-15.9%	Shares	Sole	2025-08-07
2025-03-31	$93,089	13,730	-18.3%	Shares	Sole	2025-05-08
2024-12-31	$102,397	16,814	+41.2%	Shares	Sole	2025-02-14
2024-09-30	$49,639	11,904	+15.4%	Shares	Sole	2024-11-14
2024-03-31	$62,612	10,315	+1.3%	Shares	Sole	2024-05-08
2022-03-31	$141,076	10,186	-20.2%	Shares	Sole	2022-05-10
2021-12-31	$302,946	12,761	-3.9%	Shares	Sole	2022-02-08
2021-09-30	$175,096	13,285	-15.3%	Shares	Sole	2021-11-12
2021-06-30	$243,102	15,684	+26.7%	Shares	Sole	2021-08-13
2021-03-31	$178,672	12,382	+8.9%	Shares	Sole	2021-05-14
2020-12-31	$172,217	11,375	—	Shares	Sole	2021-02-09
No filing history on record for this holder in this stock.